Q&A: Amid an M&A flurry at Charles River, longtime exec Birgit Girshick discusses how Covid-19 has changed the game
Contract research and manufacturing has been running at a rapid clip amid the pandemic, and big players in the space have looked to leverage runaway cash flow to turbocharge their business. For CRO Charles River Laboratories, that means more of everything — including a big infusion into its manufacturing arm.
In mid-May, the company paid $292.5 million for Vigene Biosciences and its 52,000 square feet of manufacturing space in Rockville, MD. In February, the company bought Cognate and pledged to double capacity in Memphis and Europe. In early April, it teamed up with Valence Discovery to expand its AI platform for molecular property prediction.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.